` Comparison: ROQ vs ARCC - Alpha Spread

R
ROQ
vs
ARCC

Over the past 12 months, ROQ has underperformed ARCC, delivering a return of -54% compared to the ARCC's 16% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ROQ
ARCC
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

R
ROQ Intrinsic Value
0.19 GBX
Overvaluation 84%
Intrinsic Value
Price
ARCC Intrinsic Value
22.579 USD
Undervaluation 15%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
R
Roquefort Therapeutics PLC
LSE:ROQ
1.2 GBX
Ares Capital Corp
NASDAQ:ARCC
19.245 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ROQ, ARCC

ROQ
ARCC
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
R
Roquefort Therapeutics PLC
Revenue
Ares Capital Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ROQ, ARCC

ROQ
ARCC
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
R
Roquefort Therapeutics PLC
LSE:ROQ
Ares Capital Corp
NASDAQ:ARCC
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ROQ
0%
ARCC
49.5%

Operating Margin

ROQ
0%
ARCC
47.8%

Net Margin

ROQ
0%
ARCC
45.2%

FCF Margin

ROQ
0%
ARCC
-51.6%

ROE

ROQ
-19.9%
ARCC
10.1%

ROA

ROQ
-16.9%
ARCC
4.7%

ROIC

ROQ
-16.6%
ARCC
4.7%

ROCE

ROQ
-21.6%
ARCC
5.1%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ROQ, ARCC

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ROQ, ARCC

Loading
ROQ
ARCC
Difference
www.alphaspread.com

Performance By Year
ROQ, ARCC

Loading
ROQ
ARCC
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ROQ to other stocks
SOFI
SoFi Technologies Inc
HAL
HAL Trust
NLY
Annaly Capital Managemen...
WPC
WP Carey Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account